The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era

HIV Medicine

Volumn 9, Issue 10, 2008, Pages 858-862

  Burkey, M D ^a,b   Wilson, L E ^a   Moore, R D ^a   Lucas, G M ^a   Francis, J ^c   Gebo, K A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteremia; HIV; MRSA; Sepsis; Staphylococcus aureus

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; BACTEREMIA; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DRUG ABUSE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; INFECTION RISK; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIVARIATE ANALYSIS; OUTPATIENT; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; UNITED STATES;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTEREMIA; CD4 LYMPHOCYTE COUNT; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; VIRAL LOAD;

EID: 55649121405     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00629.x     Document Type: Article

References (24)

1. Hidron AI, Kourbatova EV, Halvosa JS et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: Emergence of community-associated MRSA nasal carriage. Clin Infect Dis 2005; 41: 159-166.
2. Senthilkumar A, Kumar S, Sheagren JN. Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clin Infect Dis 2001; 33: 1412-1416.
3. Tumbarello M, de Gaetano Donati K, Tacconelli E et al. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother 2002; 50: 375-382.
4. Miller M, Cespedes C, Vavagiakis P, Klein RS, Lowy FD. Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis 2003; 22: 463-469.
5. Nguyen MH, Kauffman CA, Goodman RP, Squier C, Arbeit RD, Singh N. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 1999; 130: 221-225.
6. Mathews WC, Caperna JC, Barber RE et al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005; 40: 155-160.
7. Bar A, Hantschke D, Mirmohammadsadegh A, Hengge UR. Spectrum of bacterial isolates in HIV-positive patients with skin and soft tissue infections: Emergence of methicillin-resistant Staphylococci. AIDS 2003; 17: 1253-1256.
8. Lee NE, Taylor MM, Bancroft E et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis 2005; 40: 1529-1534.
9. Anderson EJ, Hawkins C, Bolon MK, Palella FJ. A series of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in HIV-infected patients. J Acquir Immune Defic Syndr 2006; 41: 125-127.
10. Skiest D, Brown K, Hester J et al. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Med 2006; 7: 361-368.
11. Gebo KA, Burkey MD, Lucas GM, Moore RD, Wilson LE. Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 2006; 43: 426-432.
12. Performance Standards for Antimicrobial Susceptibility Tests (M100-S15). Wayne, PA: Clinical and Laboratory Standards Institute, 2005.
13. Steinberg JP, Clark CC, Hackman BO. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: Impact of intravascular devices and methicillin resistance. Clin Infect Dis 1996; 23: 255-259.
14. Frimodt-Moller N, Espersen F, Skinhoj P, Rosdahl VT. Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990. Clin Microbiol Infect 1997; 3: 297-305.
15. Lyytikainen O, Ruotsalainen E, Jarvinen A, Valtonen V, Ruutu P. Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995-2001. Eur J Clin Microbiol Infect Dis 2005; 24: 399-404.
16. Fichtenbaum CJ, Dunagan WC, Powderly WG. Bacteremia in hospitalized patients infected with the human immunodeficiency virus: A case-control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 51-57.
17. Jacobson MA, Gellermann H, Chambers H. Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex. Am J Med 1988; 85: 172-176.
18. Krumholz HM, Sande MA, Lo B. Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: Clinical presentation, bacteriology, and outcome. Am J Med 1989; 86 (Part 2): 776-779.
19. Whimbey E, Gold JW, Polsky B et al. Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 104: 511-514.
20. Tuazon CU, Sheagren JN. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis 1974; 129: 725-727.
21. Pan ES, Diep BA, Charlebois ED et al. Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus -and their relation to community-associated disease activity. J Infect Dis 2005; 192: 811-818.
22. Carnicer-Pont D, Bailey KA, Mason BW, Walker AM, Evans MR, Salmon RL. Risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus bacteraemia: A case-control study. Epidemiol Infect 2006; 134: 1167-1173.
23. Karas JA, Enoch DA, Emery MM. Community-onset healthcare-associated MRSA bacteraemia in a district general hospital. J Hosp Infect 2006; 62: 480-486.
24. Reed SD, Friedman JY, Engemann JJ et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005; 26: 175-183.